Plasmodium falciparum surface proteins (MSPs)

Plasmodium falciparum surface proteins comprise a heterogeneous group of antigens predominantly expressed on the parasite surface during its asexual blood-stage (merozoites) and sexual-stage (gametocytes). The most studied is merozoite surface protein 1 (MSP-1), a large precursor processed into fragments, with the C-terminal 19-kDa region (MSP-1(19)) being highly conserved and immunogenic. These proteins play essential roles in erythrocyte invasion—mediating initial attachment, entry, and possibly escape. MSPs are GPI-anchored membrane proteins that form complexes and may interact with host cell cytoskeleton or membrane proteins. MSP-2 (involved in parasite growth and invasion) and surface-related antigen (SRA) are also important, each considered promising vaccine targets. Gametocyte surface proteins such as Pfs230 and Pfs48/45 are key for transmission-blocking vaccines on sexual stages. Despite their immunogenicity, the utility of these proteins as vaccines is complicated by high polymorphism and antigenic variation across isolates and gene families. No human drugs directly target these proteins yet, but multiple vaccines and monoclonal antibodies are in development for malaria prevention and treatment.

Other names

Merozoite surface proteinsMSPsPfMSP-1PfMSP-2Surface-related antigen (SRA)Merozoite surface antigen 180Gametocyte surface antigens (Pfs230, Pfs48/45)

Inhibition of erythrocyte invasion (neutralizing antibodies bind MSP domains to block attachment, entry, or shedding); Transmission-blocking (antibodies against gamete surface antigens prevent parasite fertilization); Immune-mediated clearance (induction of protective immune responses)